A Maximus oral advertisement and a PeterMD injection price are not two quotes for the same medicine. They describe different treatment options and different plan lengths. Before deciding which number looks easier to afford, ask what prescription and care each offer would actually provide.
This comparison examines official pages checked September 23, 2026. It does not compare patient outcomes or recommend a medication. Its purpose is to make the product, payment, and monitoring differences clear enough to support a useful conversation with a clinician.
KEEP IN MIND
A few things to remember.
- These offers describe different medicines and routes.
- Compare the full term and resolve PeterMD’s conflicting monthly total.
- Confirm laboratory costs, state access, and instructions for the exact product.
Identify the two offers being compared
Maximus describes its oral medicine as compounded native testosterone. PeterMD’s page advertises injectable testosterone cypionate. That is a route and product distinction, not simply a matter of choosing a pill instead of a needle at the same price.
Ask both providers to identify the exact dispensed product, pharmacy, and approval status. Do not infer FDA approval from a familiar active ingredient or a statement about regulated healthcare. If a preparation is compounded, ask why it is being proposed and what evidence and instructions apply to it. Our medication question guide helps make the comparison specific.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · PeterMD: injectable testosterone plans, payment terms, and state exclusions · FDA: understanding the risks of compounded drugs
Keep each price attached to its commitment
Maximus lists ordinary oral monthly rates of $249.99, $199.99, and $149.99 for one-, three-, and six-month options. Its limited six-month promotion lowers the first month to $74.99. Confirm the continuing charges, total obligation, and any dose or state-related change before relying on the displayed rate.
PeterMD shows $79 monthly equivalent for a 12-month plan totaling $948 and $109 for six months totaling $654. Its one-month presentation pairs $139 with a conflicting total elsewhere on the page. We do not resolve that inconsistency into a quote. Obtain the actual amount due and terms in writing before comparing equal periods.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · PeterMD: injectable testosterone plans, payment terms, and state exclusions
Eligibility comes before a purchase preference
PeterMD’s reviewed page excludes Alabama and Idaho. Confirm current access for your location with both practices rather than assuming online care is available everywhere. State access and medical suitability are separate questions; being able to use a website does not establish either one.
A clinician should assess symptoms, confirm appropriately low testosterone, and consider the underlying cause. If you have already started treatment elsewhere, provide the records and current prescription. The first-conversation article can help you describe the situation without making a desired product the starting assumption.
Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions · Endocrine Society: testosterone therapy clinical guidance
Ask about tests, training, and contact between visits
Maximus describes required testing and conditional acceptance of qualifying outside results from the previous six months. Ask each practice which initial and follow-up tests are required, what they cost, and who reviews them. Do not assume a medication plan includes every laboratory charge merely because it advertises ongoing care.
An injection plan should include understandable instruction and answers about supplies and disposal. An oral plan needs instructions for the exact product, including any relevant food or laboratory timing. Our oral-label guide explains why another brand’s directions cannot safely fill a gap in the prescription information.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · PeterMD: injectable testosterone plans, payment terms, and state exclusions · Endocrine Society: testosterone therapy clinical guidance
Choose using the ongoing plan, not the introductory impression
Both routes require a discussion of risks and follow-up, including blood pressure and fertility goals where relevant. Testosterone can suppress sperm production. A marketing claim about convenience, laboratory improvements, or confidence is not proof of superior safety for your circumstances.
The Maximus review and PeterMD review provide more context. Ask what happens clinically and financially if treatment must change before the paid term ends. A fair comparison brings the actual prescription, total bill, support process, and exit terms into the same conversation instead of selecting the smallest advertised monthly number.
Sources: FDA: 2025 testosterone labeling and blood pressure changes · AUA/ASRM: male infertility guideline, amended 2024
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- Maximus: compounded oral testosterone, plan prices, and laboratory requirements
- PeterMD: injectable testosterone plans, payment terms, and state exclusions
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- FDA: 2025 testosterone labeling and blood pressure changes
- AUA/ASRM: male infertility guideline, amended 2024
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.